Detalhe da pesquisa
1.
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab.
Am J Transplant
; 20(9): 2581-2588, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301258
2.
Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients.
Br J Clin Pharmacol
; 86(2): 338-351, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31658377
3.
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.
Mov Disord
; 31(7): 1049-54, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26990766
4.
Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy.
Int J Chron Obstruct Pulmon Dis
; 17: 1311-1322, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686212
5.
Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial.
BMJ Open Respir Res
; 7(1)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208303
6.
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.
Lancet Rheumatol
; 2(3): e142-e152, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263652
7.
Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure.
Int J Chron Obstruct Pulmon Dis
; 13: 1195-1205, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713153
8.
TORC1 inhibition enhances immune function and reduces infections in the elderly.
Sci Transl Med
; 10(449)2018 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997249
9.
Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1ß by Canakinumab or IL-17A by Secukinumab.
Cornea
; 34(12): 1551-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26418434
10.
Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.
Int J Radiat Oncol Biol Phys
; 88(3): 572-9, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24521675